临床荟萃

• 专题 • 上一篇    下一篇

急性冠状动脉综合征合并慢性肾脏病患者

  

  1. 河北医科大学第二医院 心内科,河北 石家庄 050000
  • 收稿日期:2016-04-15 出版日期:2016-06-05 发布日期:2016-06-06
  • 通讯作者: 通信作者:刘金明,Email:liujinming74@163.com
  • 作者简介:刘金明,河北医科大学第二医院心内 科,博士,副主任医师,擅长心血管介入治 疗(冠心病支架植入、缓慢心律失常起搏 器植入和室上速射频消融等)。

Progress in treatment strategies of patients with acute coronary

  1. Department of  Cardiology, the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China
  • Received:2016-04-15 Online:2016-06-05 Published:2016-06-06
  • Contact: Corresponding author: Liu Jinming, Email:liujinming74@163.com

摘要: 慢性肾脏病(CKD)是心血管疾病(CVD)的独立危险因素,而CVD也是CKD死亡的最主要原因。由于
肾脏病患者出血风险增加,使得针对急性冠状动脉综合征(ACS)治疗的基础药物及治疗措施使用率降低,尤其是进行
早期经皮冠状动脉介入术的治疗率低,进而使得ACS合并CKD的发病率及病死率增高。本文就ACS合并CKD的
发病机制、临床特点及治疗策略作一综述。

关键词: 急性冠状动脉综合征, 肾疾病, 经皮冠状动脉介入术

Abstract:

Chronic kidney disease (CKD) is an independent risk factor of cardiovascular disease (CVD), and CVD is the main cause of death in CKD. Because of the  increased risk of bleeding in patients with CKD and acute coronary syndrome(ACS), the basic treatment of drugs and other therapeutic measures are reduced, especially percutaneous coronary intervention treatment, which is associated with increased morbidity and mortality. This review systematically focuses on the pathogenesis, clinical characteristics and treatment strategies in patients with ACS and CKD.

Key words: acute coronary syndrome, kidney disease, percutaneous coronary intervention